Spreer A - Search Results

1

Bacterial meningitis: new therapeutic approaches.

Nau R, Djukic M, Spreer A, Eiffert H. Nau R, et al. Among authors: spreer a. Expert Rev Anti Infect Ther. 2013 Oct;11(10):1079-95. doi: 10.1586/14787210.2013.839381. Epub 2013 Sep 27. Expert Rev Anti Infect Ther. 2013. PMID: 24073921 Review.

2

Bacterial meningitis: an update of new treatment options.

Nau R, Djukic M, Spreer A, Ribes S, Eiffert H. Nau R, et al. Among authors: spreer a. Expert Rev Anti Infect Ther. 2015;13(11):1401-23. doi: 10.1586/14787210.2015.1077700. Epub 2015 Aug 18. Expert Rev Anti Infect Ther. 2015. PMID: 26293166 Review.

3

Matrix metalloproteinase-9 deficiency impairs host defense mechanisms against Streptococcus pneumoniae in a mouse model of bacterial meningitis.

Böttcher T, Spreer A, Azeh I, Nau R, Gerber J. Böttcher T, et al. Among authors: spreer a. Neurosci Lett. 2003 Mar 6;338(3):201-4. doi: 10.1016/s0304-3940(02)01406-4. Neurosci Lett. 2003. PMID: 12581831

4

Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone.

Spreer A, Kerstan H, Böttcher T, Gerber J, Siemer A, Zysk G, Mitchell TJ, Eiffert H, Nau R. Spreer A, et al. Antimicrob Agents Chemother. 2003 Aug;47(8):2649-54. doi: 10.1128/AAC.47.8.2649-2654.2003. Antimicrob Agents Chemother. 2003. PMID: 12878534 Free PMC article.

5

Experimental pneumococcal meningitis: impaired clearance of bacteria from the blood due to increased apoptosis in the spleen in Bcl-2-deficient mice.

Wellmer A, von Mering M, Spreer A, Diem R, Eiffert H, Noeske C, Bunkowski S, Gold R, Nau R. Wellmer A, et al. Among authors: spreer a. Infect Immun. 2004 Jun;72(6):3113-9. doi: 10.1128/IAI.72.6.3113-3119.2004. Infect Immun. 2004. PMID: 15155612 Free PMC article.

6

Dexamethasone increases hippocampal neuronal apoptosis in a rabbit model of Escherichia coli meningitis.

Spreer A, Gerber J, Hanssen M, Schindler S, Hermann C, Lange P, Eiffert H, Nau R. Spreer A, et al. Pediatr Res. 2006 Aug;60(2):210-5. doi: 10.1203/01.pdr.0000227553.47378.9f. Pediatr Res. 2006. PMID: 16864706

7

Antiinflammatory but no neuroprotective effects of melatonin under clinical treatment conditions in rabbit models of bacterial meningitis.

Spreer A, Gerber J, Baake D, Hanssen M, Huether G, Nau R. Spreer A, et al. J Neurosci Res. 2006 Nov 15;84(7):1575-9. doi: 10.1002/jnr.21055. J Neurosci Res. 2006. PMID: 16998917

8

Influence of subinhibitory concentrations of protein-synthesis-inhibiting antibiotics on production and release of the pneumococcal virulence factor pneumolysin in vitro.

Spreer A, von Ruden C, Mitchell TJ, Eiffert H, Nau R. Spreer A, et al. Chemotherapy. 2007;53(5):327-31. doi: 10.1159/000107691. Epub 2007 Aug 29. Chemotherapy. 2007. PMID: 17728540

9

No neuroprotective effect of erythropoietin under clinical treatment conditions in a rabbit model of Escherichia coli meningitis.

Spreer A, Gerber J, Hanssen M, Nau R. Spreer A, et al. Pediatr Res. 2007 Dec;62(6):680-3. doi: 10.1203/PDR.0b013e318159af7a. Pediatr Res. 2007. PMID: 17957150

10

Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis.

Spreer A, Lugert R, Stoltefaut V, Hoecht A, Eiffert H, Nau R. Spreer A, et al. Crit Care Med. 2009 Jul;37(7):2253-8. doi: 10.1097/CCM.0b013e3181a036c0. Crit Care Med. 2009. PMID: 19487938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters